Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Taubert Jennifer L
EVP, WWC. Innovative Medicine at Johnson & Johnson. Filing since 22 Nov 2022.
CIK 0001745938
Company
Date
Role
Action
Shares
Amount
Of holding
JNJ
Johnson & Johnson
17 Aug 2026
EVP, WWC. Innovative Medicine
Sold at will
15,000
$3.95M
7.2%
JNJ
Johnson & Johnson
4 Sep 2025
EVP, WWC. Innovative Medicine
Sold at will
56,471
$10.04M
24.1%
JNJ
Johnson & Johnson
9 Feb 2024
EVP, WW Chair, Pharmaceuticals
Sold at will
59,397
$9.28M
29.6%
JNJ
Johnson & Johnson
22 Nov 2022
EVP, WW Chair, Pharmaceuticals
Sold, plan not stated
76,923
$13.60M
37.8%
4 decisions on file.
